M, H., Z, Z., X, G., G, C., S, Z., J, L., & J, Z. (2026). Immune checkpoint inhibitor-associated diabetes mellitus: An overlooked immune-related adverse event-two case reports and a literature review. Frontiers in immunology, 17, 1831879. https://doi.org/10.3389/fimmu.2026.1831879
Chicago Style (17th ed.) CitationM, He, Zheng Z, Guo X, Cheng G, Zhang S, Liu J, and Zhao J. "Immune Checkpoint Inhibitor-associated Diabetes Mellitus: An Overlooked Immune-related Adverse Event-two Case Reports and a Literature Review." Frontiers in Immunology 17 (2026): 1831879. https://doi.org/10.3389/fimmu.2026.1831879.
MLA (9th ed.) CitationM, He, et al. "Immune Checkpoint Inhibitor-associated Diabetes Mellitus: An Overlooked Immune-related Adverse Event-two Case Reports and a Literature Review." Frontiers in Immunology, vol. 17, 2026, p. 1831879, https://doi.org/10.3389/fimmu.2026.1831879.